<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Corrigan DT</submitter><funding>NCATS NIH HHS</funding><funding>NIAID NIH HHS</funding><pagination>22-35</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9771891</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>31(1)</volume><pubmed_abstract>Antibodies to the mycobacterial surface lipoglycan lipoarabinomannan (LAM) and its related capsular polysaccharide arabinomannan (AM) are increasingly important for investigations focused on both understanding mechanisms of protection against Mycobacterium tuberculosis (Mtb) and developing next-generation point-of-care tuberculosis (TB) diagnostics. We provide here an overview of the growing pipeline of monoclonal antibodies (mAbs) to LAM/AM. Old and new methodologies for their generation are reviewed and we outline and discuss their glycan epitope specificity and other features with implications for the TB field.</pubmed_abstract><journal>Trends in microbiology</journal><pubmed_title>Monoclonal antibodies to lipoarabinomannan/arabinomannan - characteristics and implications for tuberculosis research and diagnostics.</pubmed_title><pmcid>PMC9771891</pmcid><funding_grant_id>R21 AI127173</funding_grant_id><funding_grant_id>R01 AI146329</funding_grant_id><funding_grant_id>R01 AI132680</funding_grant_id><funding_grant_id>TL1 TR002557</funding_grant_id><funding_grant_id>T32 AI070117</funding_grant_id><funding_grant_id>UL1 TR002556</funding_grant_id><funding_grant_id>R01 AI117927</funding_grant_id><funding_grant_id>TL1 TR001072</funding_grant_id><pubmed_authors>Achkar JM</pubmed_authors><pubmed_authors>Corrigan DT</pubmed_authors><pubmed_authors>Lowary TL</pubmed_authors><pubmed_authors>Ishida E</pubmed_authors><pubmed_authors>Chatterjee D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Monoclonal antibodies to lipoarabinomannan/arabinomannan - characteristics and implications for tuberculosis research and diagnostics.</name><description>Antibodies to the mycobacterial surface lipoglycan lipoarabinomannan (LAM) and its related capsular polysaccharide arabinomannan (AM) are increasingly important for investigations focused on both understanding mechanisms of protection against Mycobacterium tuberculosis (Mtb) and developing next-generation point-of-care tuberculosis (TB) diagnostics. We provide here an overview of the growing pipeline of monoclonal antibodies (mAbs) to LAM/AM. Old and new methodologies for their generation are reviewed and we outline and discuss their glycan epitope specificity and other features with implications for the TB field.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-05T15:54:38.158Z</modification><creation>2025-04-05T15:54:38.158Z</creation></dates><accession>S-EPMC9771891</accession><cross_references><pubmed>35918247</pubmed><doi>10.1016/j.tim.2022.07.001</doi></cross_references></HashMap>